QUOTE AND NEWS
Benzinga  Apr 20  Comment 
In a report published Monday, analysts at Credit Suisse initiated coverage of Medivation Inc (NASDAQ: MDVN) with a Neutral rating and a price target of $115. The analysts believe that the company's current valuation is driven by the M&A...
Benzinga  Mar 25  Comment 
In a report published Wednesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Medivation, Inc. (NASDAQ: MDVN), and raised the price target from $125.00 to $142.00. In the report, Brean Capital noted, "At the European...
Motley Fool  Mar 22  Comment 
You've got to start somewhere. Here's our top picks of biotechs with just one drug on the market.
Benzinga  Mar 11  Comment 
In a report published Wednesday, Wedbush Securities analyst David M. Nierengarten reiterated an Outperform rating on Medivation Inc. (NASDAQ: MDVN), and raised the price target from $118.00 to $138.00. In the report, Wedbush Securities noted,...
Forbes  Mar 3  Comment 
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash...
Forbes  Mar 3  Comment 
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that...
Forbes  Feb 26  Comment 
Investors in Medivation Inc (NASD: MDVN) saw new options become available today, for the April 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDVN options chain for the new April 10th contracts and...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki